Evidence map›Paper›PMID 42158119›Full record

ArticleFrontiers in medicine2026

CMRA-DETR: a lightweight and high-accuracy detection framework for MRI-based brain tumor identification.

Cai Weng, Bowei Huang, Jinghui Chen, Wei Hu, Zhiqing Huang, Punan Weng, Hongjia Zhao, Minqin Zheng

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cai WengThe Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Bowei HuangFujian University of Traditional Chinese Medicine, Fuzhou, China.
Jinghui ChenThe First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Wei HuThe Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Zhiqing HuangThe Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Punan WengFujian University of Traditional Chinese Medicine, Fuzhou, China.
Hongjia ZhaoFujian University of Traditional Chinese Medicine, Fuzhou, China.
Minqin ZhengFujian University of Traditional Chinese Medicine, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Brain tumor lesions in MRI images are characterized by low contrast, indistinct boundaries, and irregular morphology, posing substantial challenges for automated detection. RT-DETR provides an end-to-end, NMS-free detection paradigm, but its original design is optimized for natural images and exhibits three domain-specific limitations in brain tumor MRI detection: insufficient local texture perception of low-contrast lesion boundaries, neglect of feature magnitude differences in linear attention, and weak modeling of spatial continuity for morphologically irregular tumors. This study proposes CMRA-DETR (CSP-MambaOut with Retention and Magnitude-Aware Attention for Real-Time Detection Transformer), a lightweight yet high-accuracy detection framework built upon RT-DETR-R18, to address these limitations through targeted architectural adaptations. Methods: CMRA-DETR introduces three improvements: (1) a CSP-MambaOut backbone that enhances local texture perception of low-contrast lesion boundaries via gated feature selection; (2) an AIFI-MALA module that introduces magnitude-aware linear attention to correct the distributional smoothing deficiency of standard linear attention; and (3) a RetBlockC3 module that incorporates a Manhattan distance decay-based spatial retention mechanism to improve modeling of spatial continuity for morphologically irregular tumors. The model was trained and evaluated on an internal independent test set of 5,731 MRI images covering four categories (no tumor, meningioma, glioma, and pituitary adenoma), and further assessed on an external independent test set from the BRISC dataset without fine-tuning. Its performance was benchmarked against Faster R-CNN, YOLOv5n, YOLOv8n, YOLO11n, YOLO12n, and the RT-DETR-R18 baseline. Results and discussion: On the internal independent test set, CMRA-DETR achieved achieves

Indexed as

artificial intelligencebrain tumormagnetic resonance imagingobject detectionRT-DETR

Identifiers

PMID42158119
PMCPMC13180541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.